Ulcerative colitis (UC) is a chronic inflammatory condition of the colon that often brings life-disrupting symptoms like abdominal pain, diarrhea, and fatigue. For individuals who are also overweight or obese, managing UC can be even more complex—since excess weight may worsen inflammation and impact treatment response.
This clinical trial is evaluating how a combination of potential treatments may help adults living with both moderate to severe ulcerative colitis (UC) and obesity or overweight. The study is designed to assess the safety and effectiveness of this dual approach, offering participants a chance to explore care that addresses both conditions at once. By joining, individuals may access potential new therapies. They also contribute to research that could improve outcomes for others facing similar health challenges.
